Cadrenal Therapeutics, Inc. CVKD
1.13 USD +0.09 (+8.65%)
At closeNov 3, 2026, 4:00 PM EST
1.13 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
1.05 Day range 1.14
0.816 52-week range 13.11
- YTD
- -83.33%
- 1 year
- -91.62%
Financial health
Altman Z-Score
-15.55 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 3
Valuation
P/E -1.0×
FY 2022 5y median -1.4× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 4.9×
FY 2022 5y median 1.8× FY 2025
P/FCF -1.1×
FY 2022 5y median -2.6× FY 2025
EV/EBITDA -0.7×
FY 2022 5y median -0.7× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -93.2%
FY 2022 5y median -39.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -483.3%
FY 2022 5y median -125.9% FY 2025
ROIC -491.5%
FY 2022 5y median -123.1% FY 2025
ROA -305.9%
FY 2022 5y median -205.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -22.8%
FY 2022 FY 2025
EPS (diluted) 23.9%
FY 2022 FY 2025
Free Cash Flow -71.1%
FY 2022 FY 2025
Financial Health
Current Ratio 2.7×
FY 2022 5y median 3.2× FY 2025
Quick Ratio 2.7×
FY 2022 5y median 3.2× FY 2025
Debt / Equity 0.0×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2022 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2022 5y median -12.6× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31